View Future GrowthMaxnerva Technology Services 과거 순이익 실적과거 기준 점검 0/6Maxnerva Technology Services 의 수입은 연평균 -49.1%의 비율로 감소해 온 반면, IT 산업은 연평균 7.7%의 비율로 감소했습니다. 매출은 연평균 2%의 비율로 증가해 왔습니다.핵심 정보-49.08%순이익 성장률-49.47%주당순이익(EPS) 성장률IT 산업 성장률6.82%매출 성장률2.05%자기자본이익률-3.59%순이익률-2.06%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Mar 26Full year 2025 earnings released: CN¥0.021 loss per share (vs CN¥0.018 loss in FY 2024)Full year 2025 results: CN¥0.021 loss per share (further deteriorated from CN¥0.018 loss in FY 2024). Revenue: CN¥707.6m (up 27% from FY 2024). Net loss: CN¥14.6m (loss widened 17% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance.공시 • Mar 11Maxnerva Technology Services Limited to Report Fiscal Year 2025 Results on Mar 25, 2026Maxnerva Technology Services Limited announced that they will report fiscal year 2025 results on Mar 25, 2026Reported Earnings • Aug 23First half 2025 earnings released: CN¥0.003 loss per share (vs CN¥0.023 loss in 1H 2024)First half 2025 results: CN¥0.003 loss per share (improved from CN¥0.023 loss in 1H 2024). Revenue: CN¥342.1m (up 32% from 1H 2024). Net loss: CN¥2.38m (loss narrowed 85% from 1H 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance.공시 • Aug 09Maxnerva Technology Services Limited to Report First Half, 2025 Results on Aug 20, 2025Maxnerva Technology Services Limited announced that they will report first half, 2025 results on Aug 20, 2025Reported Earnings • May 04Full year 2024 earnings released: CN¥0.018 loss per share (vs CN¥0.024 loss in FY 2023)Full year 2024 results: CN¥0.018 loss per share (improved from CN¥0.024 loss in FY 2023). Revenue: CN¥558.9m (down 18% from FY 2023). Net loss: CN¥12.4m (loss narrowed 26% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 91 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 30Full year 2024 earnings released: CN¥0.018 loss per share (vs CN¥0.024 loss in FY 2023)Full year 2024 results: CN¥0.018 loss per share (improved from CN¥0.024 loss in FY 2023). Revenue: CN¥558.9m (down 18% from FY 2023). Net loss: CN¥12.4m (loss narrowed 26% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.모든 업데이트 보기Recent updatesNew Risk • May 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 49% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (HK$452.0m market cap, or US$57.7m).공시 • Apr 29Maxnerva Technology Services Limited, Annual General Meeting, Jun 03, 2026Maxnerva Technology Services Limited, Annual General Meeting, Jun 03, 2026, at 12:00 China Standard Time. Location: 303 hennessy road, wan chai, Hong KongReported Earnings • Mar 26Full year 2025 earnings released: CN¥0.021 loss per share (vs CN¥0.018 loss in FY 2024)Full year 2025 results: CN¥0.021 loss per share (further deteriorated from CN¥0.018 loss in FY 2024). Revenue: CN¥707.6m (up 27% from FY 2024). Net loss: CN¥14.6m (loss widened 17% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance.공시 • Mar 11Maxnerva Technology Services Limited to Report Fiscal Year 2025 Results on Mar 25, 2026Maxnerva Technology Services Limited announced that they will report fiscal year 2025 results on Mar 25, 2026분석 기사 • Jan 09Maxnerva Technology Services Limited (HKG:1037) Held Back By Insufficient Growth Even After Shares Climb 26%Maxnerva Technology Services Limited ( HKG:1037 ) shares have had a really impressive month, gaining 26% after a shaky...분석 기사 • Dec 04Some Investors May Be Worried About Maxnerva Technology Services' (HKG:1037) Returns On CapitalIf we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? A business...분석 기사 • Oct 29Maxnerva Technology Services Limited (HKG:1037) Not Doing Enough For Some Investors As Its Shares Slump 28%The Maxnerva Technology Services Limited ( HKG:1037 ) share price has softened a substantial 28% over the previous 30...New Risk • Sep 22New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 38% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (38% average weekly change). Earnings have declined by 42% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (HK$435.0m market cap, or US$56.0m).Buy Or Sell Opportunity • Sep 01Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to HK$0.26. The fair value is estimated to be HK$0.21, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years. Meanwhile, the company has become profitable.Reported Earnings • Aug 23First half 2025 earnings released: CN¥0.003 loss per share (vs CN¥0.023 loss in 1H 2024)First half 2025 results: CN¥0.003 loss per share (improved from CN¥0.023 loss in 1H 2024). Revenue: CN¥342.1m (up 32% from 1H 2024). Net loss: CN¥2.38m (loss narrowed 85% from 1H 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance.공시 • Aug 09Maxnerva Technology Services Limited to Report First Half, 2025 Results on Aug 20, 2025Maxnerva Technology Services Limited announced that they will report first half, 2025 results on Aug 20, 2025분석 기사 • Jun 12Maxnerva Technology Services (HKG:1037) Is In A Strong Position To Grow Its BusinessEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...Reported Earnings • May 04Full year 2024 earnings released: CN¥0.018 loss per share (vs CN¥0.024 loss in FY 2023)Full year 2024 results: CN¥0.018 loss per share (improved from CN¥0.024 loss in FY 2023). Revenue: CN¥558.9m (down 18% from FY 2023). Net loss: CN¥12.4m (loss narrowed 26% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 91 percentage points per year, which is a significant difference in performance.공시 • Apr 28Maxnerva Technology Services Limited, Annual General Meeting, May 21, 2025Maxnerva Technology Services Limited, Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Location: 2/f., j plus, 35-45b bonham strand, sheung wan, Hong KongReported Earnings • Mar 30Full year 2024 earnings released: CN¥0.018 loss per share (vs CN¥0.024 loss in FY 2023)Full year 2024 results: CN¥0.018 loss per share (improved from CN¥0.024 loss in FY 2023). Revenue: CN¥558.9m (down 18% from FY 2023). Net loss: CN¥12.4m (loss narrowed 26% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.분석 기사 • Mar 17Insufficient Growth At Maxnerva Technology Services Limited (HKG:1037) Hampers Share PriceWhen close to half the companies operating in the IT industry in Hong Kong have price-to-sales ratios (or "P/S") above...공시 • Mar 13Maxnerva Technology Services Limited to Report Fiscal Year 2024 Results on Mar 27, 2025Maxnerva Technology Services Limited announced that they will report fiscal year 2024 results on Mar 27, 2025공시 • Jan 08Maxnerva Technology Services Limited Appoints Huang Pi- Chun as Member of the Nomination CommitteeThe board of directors of Maxnerva Technology Services Limited announce that Ms. Huang Pi- Chun, a non-executive Director of the Company, has been appointed as a member of the nomination committee effective from 8 January 2025.New Risk • Sep 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 9.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.4% average weekly change). Market cap is less than US$100m (HK$214.0m market cap, or US$27.5m).분석 기사 • Sep 10Maxnerva Technology Services Limited (HKG:1037) Stock Catapults 32% Though Its Price And Business Still Lag The IndustryMaxnerva Technology Services Limited ( HKG:1037 ) shareholders would be excited to see that the share price has had a...Reported Earnings • Aug 26First half 2024 earnings released: CN¥0.023 loss per share (vs CN¥0.008 profit in 1H 2023)First half 2024 results: CN¥0.023 loss per share (down from CN¥0.008 profit in 1H 2023). Revenue: CN¥258.9m (down 27% from 1H 2023). Net loss: CN¥16.2m (down 384% from profit in 1H 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.New Risk • Aug 22New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risk Market cap is less than US$100m (HK$164.9m market cap, or US$21.2m).공시 • Aug 21Maxnerva Technology Services Limited Announces Directorate ChangesThe board (the "Board") of directors of Maxnerva Technology Services Limited (the " Company " and together with its subsidiaries, the "Group") announces that Mr. KUNG Pei-Yuan ("Mr. Kung") has tendered his resignation as non-executive Director with effect from 21 August 2024 due to his other business commitment. Mr. Kung has confirmed that he has no disagreement with the Board and there is nothing needed to be brought to the attention to the shareholders of the Company in relation to his resignation. On the same date, the Board has appointed Mr. CHANG Kuo-Chin ("Mr. Chang") as non-executive Director with effect from 21 August 2024. Mr. Chang, 56 years old, has over 30 years of extensive experience in the information technology field. He joined Hon Hai Precision Industry Co. Ltd. ("Hon Hai," along with its subsidiaries and affiliated companies, collectively referred to as the "Hon Hai Technology Group") in 1998. Hon Hai's shares are listed on the Taiwan Stock Exchange under stock code 2317. Mr. Chang specializes in information management, digital service platform establishment, and business operations. He currently serves as the senior assistant vice president and Head of the Central Information Department of Hon Hai Technology Group. Mr. Chang obtained his Bachelor's degree in Applied Mathematics from Chung Yuan Christian University in 1992 and worked in the IT department of Kuozui Motors Ltd. for three years. From 1999 to 2020, Mr. Chang led the Information Division of J Business Group at Hon Hai Technology Group, where he planned and established various central digital platforms and laid the digital operational management foundation for the rapid growth of Hon Hai Technology Group. In 2016, he founded MinMax Technology (Shenzhen) Co. Ltd. and served as Chairman until 2023, demonstrating his visionary foresight and exceptional management capabilities. Since 2013, Mr. Chang has held the positions of chairman of Futaihong Precision Component (Shenzhen) Co. Ltd., and executive director of Fuchin Precision Industry (Shenzhen) Co. Ltd. Additionally, Mr. Chang was honored as one of Hon Hai Group 's Top 10 Inventors in both 2018 and 2020.공시 • Aug 07Maxnerva Technology Services Limited to Report Q2, 2024 Results on Aug 21, 2024Maxnerva Technology Services Limited announced that they will report Q2, 2024 results on Aug 21, 2024Buy Or Sell Opportunity • May 09Now 21% undervaluedOver the last 90 days, the stock has risen 21% to HK$0.28. The fair value is estimated to be HK$0.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Meanwhile, the company became loss making.공시 • May 01Maxnerva Technology Services Limited, Annual General Meeting, May 24, 2024Maxnerva Technology Services Limited, Annual General Meeting, May 24, 2024, at 14:00 China Standard Time. Location: 2/F., J Plus,35-45B Bonham Strand Sheung Wan Hong Kong Agenda: To receive and adopt the audited financial statements and the reports of the directors and independent auditors of the Company for the year ended 31 December 2023; to re-appoint PricewaterhouseCoopers as auditors and to authorize the board of directors to fix their remuneration; to consider re-election of director and to fix the Directors' remuneration; and to consider other business issues.New Risk • Apr 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risk Market cap is less than US$100m (HK$175.4m market cap, or US$22.4m).Buy Or Sell Opportunity • Apr 23Now 27% undervaluedOver the last 90 days, the stock has risen 39% to HK$0.25. The fair value is estimated to be HK$0.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Meanwhile, the company became loss making.분석 기사 • Apr 10Maxnerva Technology Services Limited (HKG:1037) Surges 33% Yet Its Low P/S Is No Reason For ExcitementDespite an already strong run, Maxnerva Technology Services Limited ( HKG:1037 ) shares have been powering on, with a...Reported Earnings • Mar 28Full year 2023 earnings released: CN¥0.024 loss per share (vs CN¥0.04 profit in FY 2022)Full year 2023 results: CN¥0.024 loss per share (down from CN¥0.04 profit in FY 2022). Revenue: CN¥677.9m (down 19% from FY 2022). Net loss: CN¥16.8m (down 161% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 20% per year.공시 • Mar 27+ 1 more updateMaxnerva Technology Services Limited Announces Chief Executive Officer ChangesThe board of directors of Maxnerva Technology Services Limited announced that, effective from 26 March 2024: Dr. SHI Zhe (‘Dr. Shi’) has been appointed as the Chief Executive Officer in place of Mr. CAI Liting (‘Mr. Cai’). Dr. Shi, aged 34, obtained his Master and Doctor of Philosophy in Mechanical Engineering from the Center for Intelligent Maintenance Systems (IMS), University of Cincinnati, USA in 2014 and 2018 respectively. Currently he is serving as the chief digital officer and head of the smart manufacturing platform of Foxconn Technology Group, mainly responsible for the group 's digital transformation strategic planning and intelligent manufacturing implementation. Before joining Foxconn Technology Group, Dr. Shi was the co-founder of Beijing Cyberinsight Technology Co. Ltd. and was responsible for solutions and strategic key accounts. Dr. Shi has participated in the research and development of industrial intelligence projects and intelligent system development in rail transit, power generation, manufacturing, shipping and other industries. Currently, he is mainly engaged in the digital transformation of electronic manufacturing and the implementation of intelligent manufacturing projects, including mold processing, large-scale machining, printed circuit board assembly (PCBA) and large-scale assembly. Dr. Shi also serves as a lecturer for the Masters of Business and Administration (MBA) programme at the School of Economics and Management of Tsinghua University, a guest lecturer at the Graduate School of Tsinghua University on intelligent manufacturing, a business tutor for undergraduates at Beihang Sijia College, and a business tutor for professional master programme's students at Beijing Jiaotong University.공시 • Mar 13Maxnerva Technology Services Limited to Report Fiscal Year 2023 Results on Mar 26, 2024Maxnerva Technology Services Limited announced that they will report fiscal year 2023 results on Mar 26, 2024분석 기사 • Feb 21Maxnerva Technology Services Limited's (HKG:1037) Share Price Boosted 29% But Its Business Prospects Need A Lift TooMaxnerva Technology Services Limited ( HKG:1037 ) shares have continued their recent momentum with a 29% gain in the...분석 기사 • Dec 30Maxnerva Technology Services Limited's (HKG:1037) Share Price Is Matching Sentiment Around Its EarningsWhen close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 10x, you may consider...분석 기사 • Oct 12Here's What's Concerning About Maxnerva Technology Services' (HKG:1037) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...공시 • Sep 29Maxnerva Technology Services Limited Announces Board ChangesThe board of directors of Maxnerva Technology Services Limited announced that Mr. TANG Tin Lok, Stephen (Mr. Tang) has tendered his resignation as independent non-executive Director with effect from 28 September 2023 due to his other business commitment. Mr. Tang has confirmed that he has no disagreement with the board and there is nothing needed to be brought to the attention to the shareholders of the company in relation to his resignation. On the same date, the board has appointed Mr. KAM Chi Sing (Mr. Kam) as independent non-executive director with effect from 28 September 2023. Mr. Kam, aged 52, has over 22 years of experience in management accounting, auditing and assurance, taxation, corporate services and cross border merger and acquisition consultation in Hong Kong and China. Mr. Kam established Roger Kam & Co., a certified public accounting firm in Hong Kong, in May 2000, and R&T Consulting Group Limited (R&T Consulting), a business consulting firm in Hong Kong, in July 2009. Mr. Kam is currently serving as the managing partner at Roger Kam & Co, the managing director at R&T Consulting and the chief representative of the representative offices of Roger Kam & Co in Shanghai, Guangzhou and Beijing. Mr. Kam has been acting as an independent non-executive director of Excellence Commercial Property & Facilities Management Group Limited since 28 September 2020 and LX Technology Group Limited since 27 September 2022 and a company secretary of Xinji Shaxi Group Co. Ltd. since 11 March 2019, all of which are listed on the Main Board of the Stock Exchange of Hong Kong Limited. Mr. Kam is a founding member of the Alliance of Inter-Continental Accountants and has been registered as a certified tax adviser and a chartered tax adviser by the Taxation Institute of Hong Kong since 2011 and 2020, respectively. He was admitted as a fellow member of the Association of Chartered Certified Accountants in November 2003, a fellow member of the Hong Kong Institute of Certified Public Accountants in April 2006, a fellow member of the Institute of Financial Accountants in March 2011, a fellow member of the Taxation Institute of Hong Kong in January 2010, a member of the Society of Trust and Estate Practitioners in April 2012 and a member of the Hong Kong Securities and Investment Institute in June 2013, respectively. He is a committee member of the taxation committee, a committee member of the financial and treasury services committee and a committee member of the China committee of Hong Kong General Chamber of Commerce. He has also been serving as a committee member of the Chinese General Chamber of Commerce, Hong Kong since November 2016. Mr. Kam was appointed as a member and honorary treasurer of Hong Kong Red Cross Special Education & Rehabilitation Service Governing Committee in November 2013, and school manager and treasurer of the Incorporated Management Committee of Hong Kong Red Cross Princess Alexandra Schools in July 2020. Mr. Kam obtained his bachelor's degree of science from the University of Hong Kong in November 1993. The board further announced that Mr. Kam has been appointed as the chairman of the Audit Committee of the Board, and a member of Nomination Committee and Remuneration Committee of the Board with effect from 28 September 2023.Reported Earnings • Aug 31First half 2023 earnings released: EPS: CN¥0.008 (vs CN¥0.009 in 1H 2022)First half 2023 results: EPS: CN¥0.008 (down from CN¥0.009 in 1H 2022). Revenue: CN¥353.8m (down 1.4% from 1H 2022). Net income: CN¥5.70m (down 10% from 1H 2022). Profit margin: 1.6% (down from 1.8% in 1H 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.공시 • Aug 15Maxnerva Technology Services Limited to Report First Half, 2023 Results on Aug 28, 2023Maxnerva Technology Services Limited announced that they will report first half, 2023 results on Aug 28, 2023분석 기사 • Jun 29There Are Reasons To Feel Uneasy About Maxnerva Technology Services' (HKG:1037) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...Reported Earnings • Mar 30Full year 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.05 in FY 2021)Full year 2022 results: EPS: CN¥0.04 (down from CN¥0.05 in FY 2021). Revenue: CN¥832.5m (up 40% from FY 2021). Net income: CN¥27.8m (down 19% from FY 2021). Profit margin: 3.3% (down from 5.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.분석 기사 • Dec 26Maxnerva Technology Services' (HKG:1037) Returns On Capital Not Reflecting Well On The BusinessIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Non Executive Director Xiaoquan Zhang was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 01First half 2022 earnings released: EPS: CN¥0.009 (vs CN¥0.017 in 1H 2021)First half 2022 results: EPS: CN¥0.009 (down from CN¥0.017 in 1H 2021). Revenue: CN¥359.0m (up 39% from 1H 2021). Net income: CN¥6.34m (down 45% from 1H 2021). Profit margin: 1.8% (down from 4.4% in 1H 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.분석 기사 • Sep 27Maxnerva Technology Services (HKG:1037) Is Reinvesting At Lower Rates Of ReturnIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Reported Earnings • Aug 28First half 2022 earnings released: EPS: CN¥0.009 (vs CN¥0.017 in 1H 2021)First half 2022 results: EPS: CN¥0.009 (down from CN¥0.017 in 1H 2021). Revenue: CN¥359.0m (up 39% from 1H 2021). Net income: CN¥6.34m (down 45% from 1H 2021). Profit margin: 1.8% (down from 4.4% in 1H 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.공시 • Aug 18Maxnerva Technology Services Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022Maxnerva Technology Services Limited provided earnings guidance for the six months ended 30 June 2022. For the period, the Group expects to record a consolidated net profit ranging from approximately RMB 5 million to RMB 7 million as compared to approximately RMB 11.5 million in the first half of 2021.공시 • Aug 13Maxnerva Technology Services Limited to Report Q2, 2022 Results on Aug 26, 2022Maxnerva Technology Services Limited announced that they will report Q2, 2022 results on Aug 26, 2022Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Non Executive Director Xiaoquan Zhang was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 30Full year 2021 earnings released: EPS: CN¥0.05 (vs CN¥0.022 in FY 2020)Full year 2021 results: EPS: CN¥0.05 (up from CN¥0.022 in FY 2020). Revenue: CN¥596.3m (up 14% from FY 2020). Net income: CN¥34.3m (up 134% from FY 2020). Profit margin: 5.7% (up from 2.8% in FY 2020). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.분석 기사 • Mar 18Maxnerva Technology Services' (HKG:1037) Returns On Capital Are Heading HigherWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...분석 기사 • Dec 03Maxnerva Technology Services (HKG:1037) Is Experiencing Growth In Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Reported Earnings • Sep 22First half 2021 earnings released: EPS CN¥0.017 (vs CN¥0.015 in 1H 2020)The company reported a solid first half result with improved earnings and profit margins, although revenues were flat. First half 2021 results: Revenue: CN¥258.5m (flat on 1H 2020). Net income: CN¥11.5m (up 18% from 1H 2020). Profit margin: 4.4% (up from 3.8% in 1H 2020).Reported Earnings • Aug 23First half 2021 earnings released: EPS CN¥0.017 (vs CN¥0.015 in 1H 2020)The company reported a solid first half result with improved earnings and profit margins, although revenues were flat. First half 2021 results: Revenue: CN¥258.5m (flat on 1H 2020). Net income: CN¥11.5m (up 18% from 1H 2020). Profit margin: 4.4% (up from 3.8% in 1H 2020).분석 기사 • Jul 26Maxnerva Technology Services (HKG:1037) Shareholders Will Want The ROCE Trajectory To ContinueDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...분석 기사 • May 11Calculating The Intrinsic Value Of Maxnerva Technology Services Limited (HKG:1037)In this article we are going to estimate the intrinsic value of Maxnerva Technology Services Limited ( HKG:1037 ) by...Executive Departure • Apr 07Non-Executive Director has left the companyOn the 31st of March, Eui Jong Jeon's tenure as Non-Executive Director ended after 2.0 years in the role. We don't have any record of a personal shareholding under Eui Jong's name. A total of 2 executives have left over the last 12 months.분석 기사 • Apr 06Returns Are Gaining Momentum At Maxnerva Technology Services (HKG:1037)What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...Reported Earnings • Apr 02Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.018 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥523.4m (up 21% from FY 2019). Net income: CN¥14.6m (up 26% from FY 2019). Profit margin: 2.8% (up from 2.7% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.공시 • Mar 20Maxnerva Technology Services Limited to Report Fiscal Year 2020 Results on Mar 31, 2021Maxnerva Technology Services Limited announced that they will report fiscal year 2020 results on Mar 31, 2021분석 기사 • Mar 02How Much Did Maxnerva Technology Services'(HKG:1037) Shareholders Earn From Share Price Movements Over The Last Five Years?It is a pleasure to report that the Maxnerva Technology Services Limited ( HKG:1037 ) is up 33% in the last quarter...Is New 90 Day High Low • Feb 05New 90-day high: HK$0.90The company is up 58% from its price of HK$0.57 on 06 November 2020. The Hong Kong market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the IT industry, which is up 29% over the same period.분석 기사 • Feb 04Here's Why Maxnerva Technology Services' (HKG:1037) Statutory Earnings Are Arguably Too ConservativeStatistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said that...분석 기사 • Jan 14Maxnerva Technology Services Limited's (HKG:1037) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?Maxnerva Technology Services (HKG:1037) has had a great run on the share market with its stock up by a significant 31...Is New 90 Day High Low • Jan 14New 90-day high: HK$0.65The company is up 5.0% from its price of HK$0.62 on 16 October 2020. The Hong Kong market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is up 8.0% over the same period.분석 기사 • Dec 16Is There More Growth In Store For Maxnerva Technology Services' (HKG:1037) Returns On Capital?If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Is New 90 Day High Low • Oct 05New 90-day high: HK$0.47The company is up 55% from its price of HK$0.30 on 07 July 2020. The Hong Kong market is down 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the IT industry, which is up 16% over the same period.매출 및 비용 세부 내역Maxnerva Technology Services가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이SEHK:1037 매출, 비용 및 순이익 (CNY Millions)날짜매출순이익일반관리비연구개발비31 Dec 25708-1586130 Sep 25675-781130 Jun 25642176131 Mar 25601-679231 Dec 24559-1282330 Sep 24571-2688630 Jun 24583-3995931 Mar 24630-2892931 Dec 23678-1789930 Sep 23753592830 Jun 238272795731 Mar 238302895831 Dec 2283228941030 Sep 2276528961330 Jun 2269729971531 Mar 2264732921631 Dec 2159634861730 Sep 2156025751730 Jun 2152416641631 Mar 2152416641431 Dec 2052315641130 Sep 205301564830 Jun 205361565531 Mar 204831363531 Dec 194311262530 Sep 194022086330 Jun 1937428110231 Mar 1935014117131 Dec 183261124031 Dec 174475766030 Sep 173287934030 Jun 173348534031 Mar 173459235031 Dec 163612261030 Sep 16262-2355030 Jun 16178-4346031 Mar 1693-6137031 Dec 1593-2927030 Sep 1592317030 Jun 15973160양질의 수익: 1037 은(는) 현재 수익성이 없습니다.이익 마진 증가: 1037는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 1037은 수익성이 없으며 지난 5년 동안 손실이 연평균 49.1% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 1037의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: 1037은 수익성이 없어 지난 해 수익 성장률을 IT 업계(1.5%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 1037는 현재 수익성이 없으므로 자본 수익률이 음수(-3.59%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YSoftware 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 21:10종가2026/05/21 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Maxnerva Technology Services Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Mar 26Full year 2025 earnings released: CN¥0.021 loss per share (vs CN¥0.018 loss in FY 2024)Full year 2025 results: CN¥0.021 loss per share (further deteriorated from CN¥0.018 loss in FY 2024). Revenue: CN¥707.6m (up 27% from FY 2024). Net loss: CN¥14.6m (loss widened 17% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance.
공시 • Mar 11Maxnerva Technology Services Limited to Report Fiscal Year 2025 Results on Mar 25, 2026Maxnerva Technology Services Limited announced that they will report fiscal year 2025 results on Mar 25, 2026
Reported Earnings • Aug 23First half 2025 earnings released: CN¥0.003 loss per share (vs CN¥0.023 loss in 1H 2024)First half 2025 results: CN¥0.003 loss per share (improved from CN¥0.023 loss in 1H 2024). Revenue: CN¥342.1m (up 32% from 1H 2024). Net loss: CN¥2.38m (loss narrowed 85% from 1H 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance.
공시 • Aug 09Maxnerva Technology Services Limited to Report First Half, 2025 Results on Aug 20, 2025Maxnerva Technology Services Limited announced that they will report first half, 2025 results on Aug 20, 2025
Reported Earnings • May 04Full year 2024 earnings released: CN¥0.018 loss per share (vs CN¥0.024 loss in FY 2023)Full year 2024 results: CN¥0.018 loss per share (improved from CN¥0.024 loss in FY 2023). Revenue: CN¥558.9m (down 18% from FY 2023). Net loss: CN¥12.4m (loss narrowed 26% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 91 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 30Full year 2024 earnings released: CN¥0.018 loss per share (vs CN¥0.024 loss in FY 2023)Full year 2024 results: CN¥0.018 loss per share (improved from CN¥0.024 loss in FY 2023). Revenue: CN¥558.9m (down 18% from FY 2023). Net loss: CN¥12.4m (loss narrowed 26% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.
New Risk • May 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 49% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (HK$452.0m market cap, or US$57.7m).
공시 • Apr 29Maxnerva Technology Services Limited, Annual General Meeting, Jun 03, 2026Maxnerva Technology Services Limited, Annual General Meeting, Jun 03, 2026, at 12:00 China Standard Time. Location: 303 hennessy road, wan chai, Hong Kong
Reported Earnings • Mar 26Full year 2025 earnings released: CN¥0.021 loss per share (vs CN¥0.018 loss in FY 2024)Full year 2025 results: CN¥0.021 loss per share (further deteriorated from CN¥0.018 loss in FY 2024). Revenue: CN¥707.6m (up 27% from FY 2024). Net loss: CN¥14.6m (loss widened 17% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance.
공시 • Mar 11Maxnerva Technology Services Limited to Report Fiscal Year 2025 Results on Mar 25, 2026Maxnerva Technology Services Limited announced that they will report fiscal year 2025 results on Mar 25, 2026
분석 기사 • Jan 09Maxnerva Technology Services Limited (HKG:1037) Held Back By Insufficient Growth Even After Shares Climb 26%Maxnerva Technology Services Limited ( HKG:1037 ) shares have had a really impressive month, gaining 26% after a shaky...
분석 기사 • Dec 04Some Investors May Be Worried About Maxnerva Technology Services' (HKG:1037) Returns On CapitalIf we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? A business...
분석 기사 • Oct 29Maxnerva Technology Services Limited (HKG:1037) Not Doing Enough For Some Investors As Its Shares Slump 28%The Maxnerva Technology Services Limited ( HKG:1037 ) share price has softened a substantial 28% over the previous 30...
New Risk • Sep 22New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 38% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (38% average weekly change). Earnings have declined by 42% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (HK$435.0m market cap, or US$56.0m).
Buy Or Sell Opportunity • Sep 01Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to HK$0.26. The fair value is estimated to be HK$0.21, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years. Meanwhile, the company has become profitable.
Reported Earnings • Aug 23First half 2025 earnings released: CN¥0.003 loss per share (vs CN¥0.023 loss in 1H 2024)First half 2025 results: CN¥0.003 loss per share (improved from CN¥0.023 loss in 1H 2024). Revenue: CN¥342.1m (up 32% from 1H 2024). Net loss: CN¥2.38m (loss narrowed 85% from 1H 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance.
공시 • Aug 09Maxnerva Technology Services Limited to Report First Half, 2025 Results on Aug 20, 2025Maxnerva Technology Services Limited announced that they will report first half, 2025 results on Aug 20, 2025
분석 기사 • Jun 12Maxnerva Technology Services (HKG:1037) Is In A Strong Position To Grow Its BusinessEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Reported Earnings • May 04Full year 2024 earnings released: CN¥0.018 loss per share (vs CN¥0.024 loss in FY 2023)Full year 2024 results: CN¥0.018 loss per share (improved from CN¥0.024 loss in FY 2023). Revenue: CN¥558.9m (down 18% from FY 2023). Net loss: CN¥12.4m (loss narrowed 26% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 91 percentage points per year, which is a significant difference in performance.
공시 • Apr 28Maxnerva Technology Services Limited, Annual General Meeting, May 21, 2025Maxnerva Technology Services Limited, Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Location: 2/f., j plus, 35-45b bonham strand, sheung wan, Hong Kong
Reported Earnings • Mar 30Full year 2024 earnings released: CN¥0.018 loss per share (vs CN¥0.024 loss in FY 2023)Full year 2024 results: CN¥0.018 loss per share (improved from CN¥0.024 loss in FY 2023). Revenue: CN¥558.9m (down 18% from FY 2023). Net loss: CN¥12.4m (loss narrowed 26% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.
분석 기사 • Mar 17Insufficient Growth At Maxnerva Technology Services Limited (HKG:1037) Hampers Share PriceWhen close to half the companies operating in the IT industry in Hong Kong have price-to-sales ratios (or "P/S") above...
공시 • Mar 13Maxnerva Technology Services Limited to Report Fiscal Year 2024 Results on Mar 27, 2025Maxnerva Technology Services Limited announced that they will report fiscal year 2024 results on Mar 27, 2025
공시 • Jan 08Maxnerva Technology Services Limited Appoints Huang Pi- Chun as Member of the Nomination CommitteeThe board of directors of Maxnerva Technology Services Limited announce that Ms. Huang Pi- Chun, a non-executive Director of the Company, has been appointed as a member of the nomination committee effective from 8 January 2025.
New Risk • Sep 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 9.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.4% average weekly change). Market cap is less than US$100m (HK$214.0m market cap, or US$27.5m).
분석 기사 • Sep 10Maxnerva Technology Services Limited (HKG:1037) Stock Catapults 32% Though Its Price And Business Still Lag The IndustryMaxnerva Technology Services Limited ( HKG:1037 ) shareholders would be excited to see that the share price has had a...
Reported Earnings • Aug 26First half 2024 earnings released: CN¥0.023 loss per share (vs CN¥0.008 profit in 1H 2023)First half 2024 results: CN¥0.023 loss per share (down from CN¥0.008 profit in 1H 2023). Revenue: CN¥258.9m (down 27% from 1H 2023). Net loss: CN¥16.2m (down 384% from profit in 1H 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.
New Risk • Aug 22New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risk Market cap is less than US$100m (HK$164.9m market cap, or US$21.2m).
공시 • Aug 21Maxnerva Technology Services Limited Announces Directorate ChangesThe board (the "Board") of directors of Maxnerva Technology Services Limited (the " Company " and together with its subsidiaries, the "Group") announces that Mr. KUNG Pei-Yuan ("Mr. Kung") has tendered his resignation as non-executive Director with effect from 21 August 2024 due to his other business commitment. Mr. Kung has confirmed that he has no disagreement with the Board and there is nothing needed to be brought to the attention to the shareholders of the Company in relation to his resignation. On the same date, the Board has appointed Mr. CHANG Kuo-Chin ("Mr. Chang") as non-executive Director with effect from 21 August 2024. Mr. Chang, 56 years old, has over 30 years of extensive experience in the information technology field. He joined Hon Hai Precision Industry Co. Ltd. ("Hon Hai," along with its subsidiaries and affiliated companies, collectively referred to as the "Hon Hai Technology Group") in 1998. Hon Hai's shares are listed on the Taiwan Stock Exchange under stock code 2317. Mr. Chang specializes in information management, digital service platform establishment, and business operations. He currently serves as the senior assistant vice president and Head of the Central Information Department of Hon Hai Technology Group. Mr. Chang obtained his Bachelor's degree in Applied Mathematics from Chung Yuan Christian University in 1992 and worked in the IT department of Kuozui Motors Ltd. for three years. From 1999 to 2020, Mr. Chang led the Information Division of J Business Group at Hon Hai Technology Group, where he planned and established various central digital platforms and laid the digital operational management foundation for the rapid growth of Hon Hai Technology Group. In 2016, he founded MinMax Technology (Shenzhen) Co. Ltd. and served as Chairman until 2023, demonstrating his visionary foresight and exceptional management capabilities. Since 2013, Mr. Chang has held the positions of chairman of Futaihong Precision Component (Shenzhen) Co. Ltd., and executive director of Fuchin Precision Industry (Shenzhen) Co. Ltd. Additionally, Mr. Chang was honored as one of Hon Hai Group 's Top 10 Inventors in both 2018 and 2020.
공시 • Aug 07Maxnerva Technology Services Limited to Report Q2, 2024 Results on Aug 21, 2024Maxnerva Technology Services Limited announced that they will report Q2, 2024 results on Aug 21, 2024
Buy Or Sell Opportunity • May 09Now 21% undervaluedOver the last 90 days, the stock has risen 21% to HK$0.28. The fair value is estimated to be HK$0.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Meanwhile, the company became loss making.
공시 • May 01Maxnerva Technology Services Limited, Annual General Meeting, May 24, 2024Maxnerva Technology Services Limited, Annual General Meeting, May 24, 2024, at 14:00 China Standard Time. Location: 2/F., J Plus,35-45B Bonham Strand Sheung Wan Hong Kong Agenda: To receive and adopt the audited financial statements and the reports of the directors and independent auditors of the Company for the year ended 31 December 2023; to re-appoint PricewaterhouseCoopers as auditors and to authorize the board of directors to fix their remuneration; to consider re-election of director and to fix the Directors' remuneration; and to consider other business issues.
New Risk • Apr 24New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risk Market cap is less than US$100m (HK$175.4m market cap, or US$22.4m).
Buy Or Sell Opportunity • Apr 23Now 27% undervaluedOver the last 90 days, the stock has risen 39% to HK$0.25. The fair value is estimated to be HK$0.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Meanwhile, the company became loss making.
분석 기사 • Apr 10Maxnerva Technology Services Limited (HKG:1037) Surges 33% Yet Its Low P/S Is No Reason For ExcitementDespite an already strong run, Maxnerva Technology Services Limited ( HKG:1037 ) shares have been powering on, with a...
Reported Earnings • Mar 28Full year 2023 earnings released: CN¥0.024 loss per share (vs CN¥0.04 profit in FY 2022)Full year 2023 results: CN¥0.024 loss per share (down from CN¥0.04 profit in FY 2022). Revenue: CN¥677.9m (down 19% from FY 2022). Net loss: CN¥16.8m (down 161% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 20% per year.
공시 • Mar 27+ 1 more updateMaxnerva Technology Services Limited Announces Chief Executive Officer ChangesThe board of directors of Maxnerva Technology Services Limited announced that, effective from 26 March 2024: Dr. SHI Zhe (‘Dr. Shi’) has been appointed as the Chief Executive Officer in place of Mr. CAI Liting (‘Mr. Cai’). Dr. Shi, aged 34, obtained his Master and Doctor of Philosophy in Mechanical Engineering from the Center for Intelligent Maintenance Systems (IMS), University of Cincinnati, USA in 2014 and 2018 respectively. Currently he is serving as the chief digital officer and head of the smart manufacturing platform of Foxconn Technology Group, mainly responsible for the group 's digital transformation strategic planning and intelligent manufacturing implementation. Before joining Foxconn Technology Group, Dr. Shi was the co-founder of Beijing Cyberinsight Technology Co. Ltd. and was responsible for solutions and strategic key accounts. Dr. Shi has participated in the research and development of industrial intelligence projects and intelligent system development in rail transit, power generation, manufacturing, shipping and other industries. Currently, he is mainly engaged in the digital transformation of electronic manufacturing and the implementation of intelligent manufacturing projects, including mold processing, large-scale machining, printed circuit board assembly (PCBA) and large-scale assembly. Dr. Shi also serves as a lecturer for the Masters of Business and Administration (MBA) programme at the School of Economics and Management of Tsinghua University, a guest lecturer at the Graduate School of Tsinghua University on intelligent manufacturing, a business tutor for undergraduates at Beihang Sijia College, and a business tutor for professional master programme's students at Beijing Jiaotong University.
공시 • Mar 13Maxnerva Technology Services Limited to Report Fiscal Year 2023 Results on Mar 26, 2024Maxnerva Technology Services Limited announced that they will report fiscal year 2023 results on Mar 26, 2024
분석 기사 • Feb 21Maxnerva Technology Services Limited's (HKG:1037) Share Price Boosted 29% But Its Business Prospects Need A Lift TooMaxnerva Technology Services Limited ( HKG:1037 ) shares have continued their recent momentum with a 29% gain in the...
분석 기사 • Dec 30Maxnerva Technology Services Limited's (HKG:1037) Share Price Is Matching Sentiment Around Its EarningsWhen close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 10x, you may consider...
분석 기사 • Oct 12Here's What's Concerning About Maxnerva Technology Services' (HKG:1037) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...
공시 • Sep 29Maxnerva Technology Services Limited Announces Board ChangesThe board of directors of Maxnerva Technology Services Limited announced that Mr. TANG Tin Lok, Stephen (Mr. Tang) has tendered his resignation as independent non-executive Director with effect from 28 September 2023 due to his other business commitment. Mr. Tang has confirmed that he has no disagreement with the board and there is nothing needed to be brought to the attention to the shareholders of the company in relation to his resignation. On the same date, the board has appointed Mr. KAM Chi Sing (Mr. Kam) as independent non-executive director with effect from 28 September 2023. Mr. Kam, aged 52, has over 22 years of experience in management accounting, auditing and assurance, taxation, corporate services and cross border merger and acquisition consultation in Hong Kong and China. Mr. Kam established Roger Kam & Co., a certified public accounting firm in Hong Kong, in May 2000, and R&T Consulting Group Limited (R&T Consulting), a business consulting firm in Hong Kong, in July 2009. Mr. Kam is currently serving as the managing partner at Roger Kam & Co, the managing director at R&T Consulting and the chief representative of the representative offices of Roger Kam & Co in Shanghai, Guangzhou and Beijing. Mr. Kam has been acting as an independent non-executive director of Excellence Commercial Property & Facilities Management Group Limited since 28 September 2020 and LX Technology Group Limited since 27 September 2022 and a company secretary of Xinji Shaxi Group Co. Ltd. since 11 March 2019, all of which are listed on the Main Board of the Stock Exchange of Hong Kong Limited. Mr. Kam is a founding member of the Alliance of Inter-Continental Accountants and has been registered as a certified tax adviser and a chartered tax adviser by the Taxation Institute of Hong Kong since 2011 and 2020, respectively. He was admitted as a fellow member of the Association of Chartered Certified Accountants in November 2003, a fellow member of the Hong Kong Institute of Certified Public Accountants in April 2006, a fellow member of the Institute of Financial Accountants in March 2011, a fellow member of the Taxation Institute of Hong Kong in January 2010, a member of the Society of Trust and Estate Practitioners in April 2012 and a member of the Hong Kong Securities and Investment Institute in June 2013, respectively. He is a committee member of the taxation committee, a committee member of the financial and treasury services committee and a committee member of the China committee of Hong Kong General Chamber of Commerce. He has also been serving as a committee member of the Chinese General Chamber of Commerce, Hong Kong since November 2016. Mr. Kam was appointed as a member and honorary treasurer of Hong Kong Red Cross Special Education & Rehabilitation Service Governing Committee in November 2013, and school manager and treasurer of the Incorporated Management Committee of Hong Kong Red Cross Princess Alexandra Schools in July 2020. Mr. Kam obtained his bachelor's degree of science from the University of Hong Kong in November 1993. The board further announced that Mr. Kam has been appointed as the chairman of the Audit Committee of the Board, and a member of Nomination Committee and Remuneration Committee of the Board with effect from 28 September 2023.
Reported Earnings • Aug 31First half 2023 earnings released: EPS: CN¥0.008 (vs CN¥0.009 in 1H 2022)First half 2023 results: EPS: CN¥0.008 (down from CN¥0.009 in 1H 2022). Revenue: CN¥353.8m (down 1.4% from 1H 2022). Net income: CN¥5.70m (down 10% from 1H 2022). Profit margin: 1.6% (down from 1.8% in 1H 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
공시 • Aug 15Maxnerva Technology Services Limited to Report First Half, 2023 Results on Aug 28, 2023Maxnerva Technology Services Limited announced that they will report first half, 2023 results on Aug 28, 2023
분석 기사 • Jun 29There Are Reasons To Feel Uneasy About Maxnerva Technology Services' (HKG:1037) Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
Reported Earnings • Mar 30Full year 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.05 in FY 2021)Full year 2022 results: EPS: CN¥0.04 (down from CN¥0.05 in FY 2021). Revenue: CN¥832.5m (up 40% from FY 2021). Net income: CN¥27.8m (down 19% from FY 2021). Profit margin: 3.3% (down from 5.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
분석 기사 • Dec 26Maxnerva Technology Services' (HKG:1037) Returns On Capital Not Reflecting Well On The BusinessIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Non Executive Director Xiaoquan Zhang was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 01First half 2022 earnings released: EPS: CN¥0.009 (vs CN¥0.017 in 1H 2021)First half 2022 results: EPS: CN¥0.009 (down from CN¥0.017 in 1H 2021). Revenue: CN¥359.0m (up 39% from 1H 2021). Net income: CN¥6.34m (down 45% from 1H 2021). Profit margin: 1.8% (down from 4.4% in 1H 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings.
분석 기사 • Sep 27Maxnerva Technology Services (HKG:1037) Is Reinvesting At Lower Rates Of ReturnIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Reported Earnings • Aug 28First half 2022 earnings released: EPS: CN¥0.009 (vs CN¥0.017 in 1H 2021)First half 2022 results: EPS: CN¥0.009 (down from CN¥0.017 in 1H 2021). Revenue: CN¥359.0m (up 39% from 1H 2021). Net income: CN¥6.34m (down 45% from 1H 2021). Profit margin: 1.8% (down from 4.4% in 1H 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
공시 • Aug 18Maxnerva Technology Services Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022Maxnerva Technology Services Limited provided earnings guidance for the six months ended 30 June 2022. For the period, the Group expects to record a consolidated net profit ranging from approximately RMB 5 million to RMB 7 million as compared to approximately RMB 11.5 million in the first half of 2021.
공시 • Aug 13Maxnerva Technology Services Limited to Report Q2, 2022 Results on Aug 26, 2022Maxnerva Technology Services Limited announced that they will report Q2, 2022 results on Aug 26, 2022
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Non Executive Director Xiaoquan Zhang was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 30Full year 2021 earnings released: EPS: CN¥0.05 (vs CN¥0.022 in FY 2020)Full year 2021 results: EPS: CN¥0.05 (up from CN¥0.022 in FY 2020). Revenue: CN¥596.3m (up 14% from FY 2020). Net income: CN¥34.3m (up 134% from FY 2020). Profit margin: 5.7% (up from 2.8% in FY 2020). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.
분석 기사 • Mar 18Maxnerva Technology Services' (HKG:1037) Returns On Capital Are Heading HigherWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...
분석 기사 • Dec 03Maxnerva Technology Services (HKG:1037) Is Experiencing Growth In Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...
Reported Earnings • Sep 22First half 2021 earnings released: EPS CN¥0.017 (vs CN¥0.015 in 1H 2020)The company reported a solid first half result with improved earnings and profit margins, although revenues were flat. First half 2021 results: Revenue: CN¥258.5m (flat on 1H 2020). Net income: CN¥11.5m (up 18% from 1H 2020). Profit margin: 4.4% (up from 3.8% in 1H 2020).
Reported Earnings • Aug 23First half 2021 earnings released: EPS CN¥0.017 (vs CN¥0.015 in 1H 2020)The company reported a solid first half result with improved earnings and profit margins, although revenues were flat. First half 2021 results: Revenue: CN¥258.5m (flat on 1H 2020). Net income: CN¥11.5m (up 18% from 1H 2020). Profit margin: 4.4% (up from 3.8% in 1H 2020).
분석 기사 • Jul 26Maxnerva Technology Services (HKG:1037) Shareholders Will Want The ROCE Trajectory To ContinueDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
분석 기사 • May 11Calculating The Intrinsic Value Of Maxnerva Technology Services Limited (HKG:1037)In this article we are going to estimate the intrinsic value of Maxnerva Technology Services Limited ( HKG:1037 ) by...
Executive Departure • Apr 07Non-Executive Director has left the companyOn the 31st of March, Eui Jong Jeon's tenure as Non-Executive Director ended after 2.0 years in the role. We don't have any record of a personal shareholding under Eui Jong's name. A total of 2 executives have left over the last 12 months.
분석 기사 • Apr 06Returns Are Gaining Momentum At Maxnerva Technology Services (HKG:1037)What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...
Reported Earnings • Apr 02Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.018 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥523.4m (up 21% from FY 2019). Net income: CN¥14.6m (up 26% from FY 2019). Profit margin: 2.8% (up from 2.7% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
공시 • Mar 20Maxnerva Technology Services Limited to Report Fiscal Year 2020 Results on Mar 31, 2021Maxnerva Technology Services Limited announced that they will report fiscal year 2020 results on Mar 31, 2021
분석 기사 • Mar 02How Much Did Maxnerva Technology Services'(HKG:1037) Shareholders Earn From Share Price Movements Over The Last Five Years?It is a pleasure to report that the Maxnerva Technology Services Limited ( HKG:1037 ) is up 33% in the last quarter...
Is New 90 Day High Low • Feb 05New 90-day high: HK$0.90The company is up 58% from its price of HK$0.57 on 06 November 2020. The Hong Kong market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the IT industry, which is up 29% over the same period.
분석 기사 • Feb 04Here's Why Maxnerva Technology Services' (HKG:1037) Statutory Earnings Are Arguably Too ConservativeStatistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said that...
분석 기사 • Jan 14Maxnerva Technology Services Limited's (HKG:1037) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?Maxnerva Technology Services (HKG:1037) has had a great run on the share market with its stock up by a significant 31...
Is New 90 Day High Low • Jan 14New 90-day high: HK$0.65The company is up 5.0% from its price of HK$0.62 on 16 October 2020. The Hong Kong market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is up 8.0% over the same period.
분석 기사 • Dec 16Is There More Growth In Store For Maxnerva Technology Services' (HKG:1037) Returns On Capital?If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Is New 90 Day High Low • Oct 05New 90-day high: HK$0.47The company is up 55% from its price of HK$0.30 on 07 July 2020. The Hong Kong market is down 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the IT industry, which is up 16% over the same period.